Antibiotics Market was valued at USD 43734.5 million in 2020 and is projected to reach USD 53837.1 million by 2030, growing at an approximate CAGR of 2.1% during the forecast period.Antibiotics are a group of medicines used in the treatment of any disease or infections caused by microbial organisms. Antibiotics are also called antibacterial or antimicrobials since they created to kill certain microorganisms and parasites which target our immune system and healthy cells.  The discovery of penicillin in the year 1920 has marked a major discovery in mankind, which has resulted in the saving of many lives. There have been several discoveries thereafter in the field of medicine and constant development process is there in the field of medicine.  Antibiotics have the strength of curing several diseases like step throat, urinary tract infection, sinus infection, fever, pneumonia, skin infections, ear & nose infection, and others.

Market Segmentation:

The global antibiotic market is segmented by class into beta-lactam & beta-lactamase inhibitors, quinolone, macrolide, and others. Beta-lactam & beta-lactamase inhibitors class are further sub-divided into penicillin, cephalosporin, carbapenem, and monobactam. By drug origin, the market is segregated into natural, semisynthetic, and synthetic.  By spectrum of activity, the market is categorized into broad-spectrum antibiotics and narrow-spectrum antibiotics. By route of administration the market is segmented into oral, intravenous, and others. By geography, the market is divided into North America, Asia Pacific, Europe, and RoW. 

Market Dynamics and Factors:

The global antibiotic market is growing rapidly owing to the rise in the consumption of antibiotics in developing nations, investment in R&D, and due to the rise in the prevalence of infectious diseases. However, drug approval costs and antibiotic resistance are slowing the market growth. On the other hand, the success in discoveries of advanced drugs and the introduction of therapies to treat antibiotic-resistant microbial infections will raise market growth.

Geographic Analysis:

Asia Pacific region has dominated the market in the year 2017, showing the highest shares and is anticipated to dominate the market during the forecasted period. The rise in the consumption of antibiotics due to several diseases like SARS, Ebola, and others, which has driven the demand for antibiotics. The region is likely to present significant opportunities during the forecast period due to the prevalence of various infectious diseases, favorable regulatory reforms, an increase in population & unhygienic conditions giving rise to antibiotic resistance bacteria, and significant demand for generic medicines.

Competitive Scenario:

The key players in the global antibiotic market are Allergan Plc., F.Hoffmann-La Roche Ltd., Abbott Laboratories, GlaxoSmithKline Plc, Mylan N.V., Merck & Co. Inc., Novartis International AG (Sandoz), Sanofi, Pfizer Inc., Teva Pharmaceutical Industries Ltd. Aurobindo Pharma, Lupin Pharmaceuticals,Bayer Healthcare, Eli Lilly, Sun Pharmaceutical, Shionogi, and others.

Antibiotics Market Report Scope